Purple Biotech Ltd ADR
(PPBT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 4,739 | 3,042 | 0 | 6,531 | 0 |
| Operating Income | -4,739 | -3,042 | N/A | -6,531 | N/A |
| Interest Expense | 69 | 21 | 0 | 20 | 0 |
| Other Income | 56 | 68 | 0 | 118 | 0 |
| Pre-tax Income | -4,752 | -2,995 | 0 | -6,433 | 0 |
| Net Income Continuous | -4,752 | -2,995 | N/A | -6,433 | N/A |
| Net Income Discontinuous | -354 | -154 | N/A | -136 | N/A |
| Minority Interests | -34 | -12 | N/A | -22 | N/A |
| Net Income | $-5,072 | $-3,137 | $N/A | $-6,547 | $N/A |
| EPS Basic Total Ops | -13.40 | -3.60 | N/A | -7.40 | N/A |
| EPS Basic Continuous Ops | -5.33 | -3.40 | N/A | -7.40 | N/A |
| EPS Basic Discontinuous Ops | -0.40 | -0.17 | N/A | -0.16 | N/A |
| EPS Diluted Total Ops | -13.20 | -3.60 | N/A | -7.60 | N/A |
| EPS Diluted Continuous Ops | -5.33 | -3.40 | N/A | -7.40 | N/A |
| EPS Diluted Discontinuous Ops | -0.40 | -0.17 | N/A | -0.16 | N/A |
| EBITDA(a) | $-4,678 | $-2,979 | $N/A | $-6,485 | $N/A |